Original Article Proteomic Analysis of Whole Saliva in Relation to Dental Caries Resistance

Total Page:16

File Type:pdf, Size:1020Kb

Original Article Proteomic Analysis of Whole Saliva in Relation to Dental Caries Resistance Original Article Proteomic Analysis of Whole Saliva in Relation to Dental Caries Resistance (dental caries / fractions of whole human saliva / label-free quantification / mass spectrometry / proteins) L. KulhavÁ1, 2, A. ECKHARDT2, S. Pataridis2, R. Foltán3, I. MIKŠÍK2 1Department of Analytical Chemistry, Faculty of Science, Charles University, Prague, Czech Republic 2Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic 3Department of Stomatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic Abstract. Saliva contains possible biomarkers that Received: November 29, 2019. Accepted: March 10, 2020. are associated with dental caries. The present study This work was supported by Charles University, project GA UK aimed to analyse differences in the abundance of No. 322216, within the framework of Specific University Re- proteins in the saliva between caries-positive (CP; search (SVV 260560), and by the Czech Science Foundation (No. N = 15) and caries-free (CF; N = 12) males and to 17-31564A). compare differences in the abundance of proteins be- Corresponding author: Lucie Kulhavá, Institute of Physiology of tween two saliva sample fractions (supernatant and the Czech Academy of Sciences, Vídeňská 1083, 142 20 Prague pellet). We found 14 differently significantly ex- 4, Czech Republic. Phone: (+420) 241 06 2127; e-mail: lucie. pressed proteins in the CF group when comparing [email protected] the supernatant fractions of the CP and CF groups, Abbreviations: AMY1C – α-amylase 1 (IPI00300786), ALB – se- and three proteins in the pellet fractions had signifi- rum albumin (IPI00745872), AZGP1 – zinc-α-2-glycoprotein cantly higher expression in the CP group. Our results (IPI00166729), BPIFB1 – BPI fold-containing family B member indicate very specific protein compositions of the sa- 1 (IPI00291410), BPIFB2 – BPI fold-containing family B mem- liva in relation to dental caries resistance (the saliva ber 2 (IPI00296654), CA6 – carbonic anhydrase 6 (IPI00295105), of the CP group mainly contained pellet proteins and CSTB – cystatin-B (IPI00021828), CST1 – cystatin-SN (IPI00305477), CST4 – cystatin-S (IPI00032294), CRNN – cor- the saliva of the CF group mainly contained superna- nulin (IPI00297056), C6orf58 – protein LEG1 homologue tant proteins). This was the first time that the saliva (IPI00374315), FDR – false discovery rate, GO – gene ontology, pellet fraction was analysed in relation to the dental HSPB1 – heat-shock protein β 1 (IPI00025512), H3F3A – histone caries status. We detected specific calcium-binding H3.3 (IPI00909530), IGHA1 – immunoglobulin heavy constant α proteins that could have decalcified enamel in the sa- 1 (IPI00386879), Ig heavy chain V-III – immunglobulin heavy liva pellet of the CP group. We also observed signifi- chain V-III region (IPI00854644), IGJ – immunoglobulin J chain cantly up-regulated immune proteins in the saliva (IPI00947235), IGK@ IGK@ – IGK@ IGK@ protein supernatant of the CF group that could play an im- (IPI00784985), IGLV1-44 – immunoglobulin λ variable 1-44 portant role in the caries prevention. The particular (IPI00887169), JUP – junction plakoglobin (IPI00554711), KR- T6A – keratin, type II cytoskeletal 6A (IPI00909059), KRT1 – protein compositions of the saliva pellet and super- keratin, type II cytoskeletal 1 (IPI00220327), KRT4 – keratin, natant in the groups with different susceptibilities to type II cytoskeletal 4 (IPI01022175), KRT5 – keratin, type II cy- tooth decay is a promising finding for future research. toskeletal 5 (IPI00009867), KRT13 – keratin, type I cytoskeletal 13 (IPI00009866), KRT13 GUCA1B – KRT13 GUCA1B protein (IPI00930614), LCN1 – lipocalin-1 (IPI00009650), LTF – lac- Introduction totransferrin (IPI00925547), LYZ – lysozyme C (IPI00019038), Oral fluids are very important in oral health. The MS – mass spectrometry, PIGR – polymeric immunoglobulin re- physiology of human saliva and salivary secretion were ceptor (IPI00004573), PIP – prolactin-inducible protein reviewed in Proctor (2016). Saliva includes many mark- (IPI00022974), RAB10 – Ras-related protein Rab 10 (IPI00016513), S100A8 – protein S100-A8 (IPI00007047), ers that can indicate a risk of certain diseases (Podzimek S100A9 – protein S100-A9 (IPI00027462), S100A14 – protein et al., 2016). Possible biomarkers for dental caries, such S100-A14 (IPI00010214), TF – serotransferrin (IPI00022463), as salivary electrolytes, microorganisms, proteins and TGM3 – protein-glutamine γ-glutamyltransferase E (IPI00300376), peptides, were also previously reviewed along with the ZG16B – zymogen granule protein (IPI00060800). functional properties of saliva (Gao et al., 2016). Only a Folia Biologica (Praha) 66, 72-80 (2020) Vol. 66 Pellet in Proteomic Analysis of Saliva 73 small part of the population at the age of 30 is classified tease activity. The unstimulated whole-saliva samples as caries-free, and the reason for the resistance is un- were frozen at –80 °C until further analysis. known. There are limited studies on the differences in the saliva protein composition between persons with Initial sample preparation carious teeth and persons without caries (Al-Tarawneh The saliva samples (700 μl) were centrifuged at et al., 2011; Laputková et al., 2018). Differences in the 13,000 g for 30 min at 4 °C. The supernatant and pellet abundance of salivary proteins between caries-suscepti- (P) of each sample were retained separately. The ob- ble and caries-free persons and a gender comparison tained supernatants and pellets were then aliquoted for were presented in our previous study (Kulhavá et al., use. Each sample was divided into seven parts; four 2018). Age-specific variations in the salivary proteome parts were used for two-dimensional electrophoresis, of caries-susceptible adults and elderly people have also two parts were used for two-dimensional difference gel been investigated (Wang et al., 2018a). The influence of electrophoresis and one part was used for MS analysis salivary protein composition on in vitro dental pellicle and label-free (LF) quantification. The pellets were ly- and their correlation with dental caries was studied by ophilised before distribution. Seven samples (super- two-dimensional electrophoresis (Vitorino et al., 2006). natant/pellet) of human saliva (caries-positive, N = 7; Salivary protein roles as predictors of caries risk were caries-free, N = 7) were used for two-dimensional elec- described in a recent review (Laputková et al., 2018). trophoresis because high variability between each saliva However, studies on the protein composition of saliva sample was identified (verified by the previous one-di- in relation to dental caries have varied (different ap- mensional electrophoresis), along with different protein proaches, methods, and use of gender-based compari- concentrations in individual saliva samples. Four sam- sons). A study by Vitorino et al. described an assessment ples (supernatant/pellet) of human saliva (caries-posi- of pre-treatment saliva samples using in-gel and off-gel tive, N = 4; caries-free, N = 4) were analysed by two- approaches, and they were the first to present the pellet dimensional difference gel electrophoresis because of fraction protein content (but not related to caries) the cost of access method. (Vitorino et al., 2012). All comparative studies of caries- positive and caries-free individuals have analysed only Preparation of samples for two-dimensional the supernatant saliva fraction. The present study, based electrophoresis and two-dimensional difference on analyses by mass spectrometry (MS) (and label-free gel electrophoresis mass spectrometry quantification), was performed to compare differences in the salivary protein abundance Supernatant proteins were precipitated using a final between caries-free and caries-positive males. We com- concentration of 10% (v/v) trichloroacetic acid and pared differences in the abundance of proteins in two 0.12% (w/v) dithiothreitol (Jehmlich et al., 2013). After saliva sample fractions: the supernatant and the pellet. vortexing followed by incubation at 25 °C for 15 min, Here, the pellets were analysed in this way for the first the precipitated protein was concentrated by centrifuga- time, and a unique comparison between these saliva tion (13,000 g, 15 min, 4 °C). Then we used a protocol fractions was carried out. modified from Gonçalves et al. (2011); ice-cold acetone was used without dithiothreitol. Protein pellets from the Material and Methods collected supernatants (S) were washed three times with ice-cold 100% acetone, lyophilised and stored at –80 °C. Saliva sample collection Pellet proteins (P) were washed with ice-cold acetone and acetonitrile, lyophilised and stored –80 °C. Unstimulated whole saliva was collected from 27 healthy male non-smoking volunteers (without diabetes MS sample preparation – supernatant (S) and mellitus). The subjects were categorized according to pellet (P) protein the DMFT index (decayed, missing, and filled teeth in- dex) into two groups: caries-positive (CP) (N = 15, aged Protein from supernatant and pellet samples was ob- 38.4 ± 5.6, DMFT ranging from 7 to 12) and caries-free tained similarly as in the sample preparation for the two- (CF) (N = 12, aged 31.8 ± 7.6, DMFT ranging from 0 (N dimensional gel electrophoresis. Pellet proteins were = 10) to 1(N= 2)). All procedures performed in the stud- digested in a solution containing 0.1 M NH4HCO3 and ies involving human participants were in accordance 0.2 M trypsin
Recommended publications
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • (COPD) and Lung Cancer by Means of Cell Specific
    UNDERSTANDING SHARED PATHOGENESIS BETWEEN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND LUNG CANCER BY MEANS OF CELL SPECIFIC GENOMICS CLARA EMILY GREEN A thesis submitted to the University of Birmingham for the degree of DOCTOR OF PHILOSOPHY The Institute of Inflammation and Ageing College of Medical and Dental Sciences University of Birmingham February 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. Abstract Introduction COPD (Chronic Obstructive Pulmonary Disease) and lung cancer are related conditions associated with inflammation. Relatively little focus has been given to the endothelium, through which inflammatory cells transmigrate to reach the lung. We sought to determine if coding and non-coding alterations in pulmonary endothelium exist in COPD and lung cancer. Methods Patients with and without COPD undergoing thoracic surgery were recruited. Pulmonary Endothelial Cells were isolated from lung and tumour and extracted RNA (ribonucleic acid) used for miRNA (micro-RNA) and mRNA (messenger RNA) microarrays. Ingenuity pathway analysis (IPA) was also carried out. Results 2071 genes and 43 miRNAs were significantly upregulated in COPD. 4 targets were validated by quantitative polymerase chain reaction, of which miR-181b-3p was chosen for functional validation.
    [Show full text]
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
    [Show full text]
  • Molecular Determinants of Guanylate Cyclase Activating Protein
    www.nature.com/scientificreports OPEN Molecular determinants of Guanylate Cyclase Activating Protein subcellular distribution in Received: 1 August 2017 Accepted: 26 January 2018 photoreceptor cells of the retina Published: xx xx xxxx Santiago López-Begines 1,2, Anna Plana-Bonamaisó2 & Ana Méndez 1,2 Retinal guanylate cyclase (RetGC) and guanylate cyclase activating proteins (GCAPs) play an important role during the light response in photoreceptor cells. Mutations in these proteins are linked to distinct forms of blindness. RetGC and GCAPs exert their role at the ciliary outer segment where phototransduction takes place. We investigated the mechanisms governing GCAP1 and GCAP2 distribution to rod outer segments by expressing selected GCAP1 and GCAP2 mutants as transient transgenes in the rods of GCAP1/2 double knockout mice. We show that precluding GCAP1 direct binding to RetGC (K23D/GCAP1) prevented its distribution to rod outer segments, while preventing GCAP1 activation of RetGC post-binding (W94A/GCAP1) did not. We infer that GCAP1 translocation to the outer segment strongly depends on GCAP1 binding afnity for RetGC, which points to GCAP1 requirement to bind to RetGC to be transported. We gain further insight into the distinctive regulatory steps of GCAP2 distribution, by showing that a phosphomimic at position 201 is sufcient to retain GCAP2 at proximal compartments; and that the bovine equivalent to blindness-causative mutation G157R/GCAP2 results in enhanced phosphorylation in vitro and signifcant retention at the inner segment in vivo, as likely contributing factors to the pathophysiology. Retinal guanylate cyclases (RetGCs) and guanylate cyclase activating proteins (GCAPs) play a central role in pho- toreceptor cells of the retina.
    [Show full text]
  • Interaction of GCAP1 with Retinal Guanylyl Cyclase and Calcium: Sensitivity to Fatty Acylation
    ORIGINAL RESEARCH ARTICLE published: 22 February 2012 MOLECULAR NEUROSCIENCE doi: 10.3389/fnmol.2012.00019 Interaction of GCAP1 with retinal guanylyl cyclase and calcium: sensitivity to fatty acylation Igor V. Peshenko , Elena V. Olshevskaya and Alexander M. Dizhoor* Department of Basic Science and Pennsylvania College of Optometry, Salus University, Elkins Park, PA, USA Edited by: Guanylyl cyclase activating proteins (GCAPs) are calcium/magnesium binding proteins Michael R. Kreutz, Leibniz-Institute within neuronal calcium sensor proteins group (NCS) of the EF-hand proteins superfamily. for Neurobiology, Germany GCAPs activate retinal guanylyl cyclase (RetGC) in vertebrate photoreceptors in response Reviewed by: to light-dependent fall of the intracellular free Ca2+ concentrations. GCAPs consist of four Carlo Sala, CNR Institute of Neuroscience, Italy EF-hand domains and contain N-terminal fatty acylated glycine, which in GCAP1 is required Karl-Wilhelm Koch, Carl von for the normal activation of RetGC. We analyzed the effects of a substitution prohibiting Ossietzky University Oldenburg, N-myristoylation (Gly2 → Ala) on the ability of the recombinant GCAP1 to co-localize with Germany its target enzyme when heterologously expressed in HEK293 cells. We also compared *Correspondence: Ca2+ binding and RetGC-activating properties of the purified non-acylated G2A mutant and Alexander M. Dizhoor, Department of Basic Science and Pennsylvania C14:0 acylated GCAP1 in vitro. The G2A GCAP1 expressed with a C-terminal GFP tag was College of Optometry, Salus able to co-localize with the cyclase, albeit less efficiently than the wild type, but much less University, 8360 Old York Road, effectively stimulated cyclase activity in vitro.Ca2+ binding isotherm of the G2A GCAP1 Elkins Park, PA 19027, USA.
    [Show full text]
  • Structure, Function, and Therapeutic Use of Igm Antibodies
    antibodies Review Structure, Function, and Therapeutic Use of IgM Antibodies Bruce A. Keyt *, Ramesh Baliga, Angus M. Sinclair, Stephen F. Carroll and Marvin S. Peterson IGM Biosciences Inc, 325 East Middlefield Road, Mountain View, CA 94043, USA; [email protected] (R.B.); [email protected] (A.M.S.); [email protected] (S.F.C.); [email protected] (M.S.P.) * Correspondence: [email protected]; Tel.: +1-650-265-6458 Received: 16 September 2020; Accepted: 9 October 2020; Published: 13 October 2020 Abstract: Natural immunoglobulin M (IgM) antibodies are pentameric or hexameric macro- immunoglobulins and have been highly conserved during evolution. IgMs are initially expressed during B cell ontogeny and are the first antibodies secreted following exposure to foreign antigens. The IgM multimer has either 10 (pentamer) or 12 (hexamer) antigen binding domains consisting of paired µ heavy chains with four constant domains, each with a single variable domain, paired with a corresponding light chain. Although the antigen binding affinities of natural IgM antibodies are typically lower than IgG, their polyvalency allows for high avidity binding and efficient engagement of complement to induce complement-dependent cell lysis. The high avidity of IgM antibodies renders them particularly efficient at binding antigens present at low levels, and non-protein antigens, for example, carbohydrates or lipids present on microbial surfaces. Pentameric IgM antibodies also contain a joining (J) chain that stabilizes the pentameric structure and enables binding to several receptors. One such receptor, the polymeric immunoglobulin receptor (pIgR), is responsible for transcytosis from the vasculature to the mucosal surfaces of the lung and gastrointestinal tract.
    [Show full text]
  • Circulating Plasmablasts/Plasma Cells
    Lin et al. Arthritis Research & Therapy (2017) 19:25 DOI 10.1186/s13075-017-1231-2 RESEARCHARTICLE Open Access Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease Wei Lin1,2†, Panpan Zhang1†, Hua Chen1, Yu Chen1, Hongxian Yang1, Wenjie Zheng1, Xuan Zhang1, Fengxiao Zhang2, Wen Zhang1* and Peter E. Lipsky3* Abstract Background: Immunoglobulin G4 (IgG4)-related disease (IgG4-RD) is a multisystem fibroinflammatory disease. We previously reported that a circulating cell population expressing CD19+CD24−CD38hi was increased in patients with IgG4-RD. In this study, we aimed to document that this cell population represented circulating plasmablasts/plasma cells, to identify the detailed phenotype and gene expression profile of these IgG4-secreting plasmablasts/plasma cells, and to determine whether this B-cell lineage subset could be a biomarker in IgG4-related disease (IgG4-RD). Methods: A total of 42 untreated patients with IgG4-RD were evaluated. Peripheral B-cell subsets, including CD19 +CD24−CD38hi plasmablasts/plasma cells, CD19+CD24+CD38− memory B cells, CD19+CD24intCD38int naïve B cells, and CD19+CD24hiCD38hi regulatory B cells, were assessed and sorted by flow cytometry. Microarray analysis was used to measure gene expression of circulating B-cell lineage subsets. Further characterization of CD19+CD24 −CD38hi plasmablasts/plasma cells was carried out by evaluating additional surface markers, including CD27, CD95, and human leukocyte antigen (HLA)-DR, by flow cytometric assay. In addition, various B-cell lineage subsets were cultured in vitro and IgG4 concentrations were measured by cytometric bead array. Results: In untreated patients with IgG4-RD, the peripheral CD19+CD24−CD38hi plasmablast/plasma cell subset was increased and positively correlated with serum IgG4 levels, the number of involved organs, and the IgG4-related Disease Responder Index.
    [Show full text]
  • New Approach for Untangling the Role of Uncommon Calcium-Binding Proteins in the Central Nervous System
    brain sciences Review New Approach for Untangling the Role of Uncommon Calcium-Binding Proteins in the Central Nervous System Krisztina Kelemen * and Tibor Szilágyi Department of Physiology, Doctoral School, Faculty of Medicine, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540142 Târgu Mures, , Romania; [email protected] * Correspondence: [email protected]; Tel.: +40-746-248064 Abstract: Although Ca2+ ion plays an essential role in cellular physiology, calcium-binding proteins (CaBPs) were long used for mainly as immunohistochemical markers of specific cell types in different regions of the central nervous system. They are a heterogeneous and wide-ranging group of proteins. Their function was studied intensively in the last two decades and a tremendous amount of informa- tion was gathered about them. Girard et al. compiled a comprehensive list of the gene-expression profiles of the entire EF-hand gene superfamily in the murine brain. We selected from this database those CaBPs which are related to information processing and/or neuronal signalling, have a Ca2+- buffer activity, Ca2+-sensor activity, modulator of Ca2+-channel activity, or a yet unknown function. In this way we created a gene function-based selection of the CaBPs. We cross-referenced these findings with publicly available, high-quality RNA-sequencing and in situ hybridization databases (Human Protein Atlas (HPA), Brain RNA-seq database and Allen Brain Atlas integrated into the HPA) and created gene expression heat maps of the regional and cell type-specific expression levels of the selected CaBPs. This represents a useful tool to predict and investigate different expression patterns and functions of the less-known CaBPs of the central nervous system.
    [Show full text]
  • Chain-Deficient Igm Structural and Functional Analysis of J
    Structural and Functional Analysis of J Chain-Deficient IgM Erik J. Wiersma, Cathy Collins, Shafie Fazel and Marc J. Shulman This information is current as J Immunol 1998; 160:5979-5989; ; of September 25, 2021. http://www.jimmunol.org/content/160/12/5979 References This article cites 44 articles, 19 of which you can access for free at: Downloaded from http://www.jimmunol.org/content/160/12/5979.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: by guest on September 25, 2021 http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Structural and Functional Analysis of J Chain-Deficient IgM1 Erik J. Wiersma, Cathy Collins, Shafie Fazel, and Marc J. Shulman2 Previous studies have discerned two forms of polymeric mouse IgM: moderately cytolytic (complement-activating) pentamer, which contains J chain, and highly cytolytic hexamer, which lacks J chain. To investigate the relationships among polymeric structure, J chain content, and cytolytic activity, we produced IgM in J chain-deficient and J chain-proficient mouse hybridoma cell lines.
    [Show full text]
  • Gene Expression in the Mouse Eye: an Online Resource for Genetics Using 103 Strains of Mice
    Molecular Vision 2009; 15:1730-1763 <http://www.molvis.org/molvis/v15/a185> © 2009 Molecular Vision Received 3 September 2008 | Accepted 25 August 2009 | Published 31 August 2009 Gene expression in the mouse eye: an online resource for genetics using 103 strains of mice Eldon E. Geisert,1 Lu Lu,2 Natalie E. Freeman-Anderson,1 Justin P. Templeton,1 Mohamed Nassr,1 Xusheng Wang,2 Weikuan Gu,3 Yan Jiao,3 Robert W. Williams2 (First two authors contributed equally to this work) 1Department of Ophthalmology and Center for Vision Research, Memphis, TN; 2Department of Anatomy and Neurobiology and Center for Integrative and Translational Genomics, Memphis, TN; 3Department of Orthopedics, University of Tennessee Health Science Center, Memphis, TN Purpose: Individual differences in patterns of gene expression account for much of the diversity of ocular phenotypes and variation in disease risk. We examined the causes of expression differences, and in their linkage to sequence variants, functional differences, and ocular pathophysiology. Methods: mRNAs from young adult eyes were hybridized to oligomer microarrays (Affymetrix M430v2). Data were embedded in GeneNetwork with millions of single nucleotide polymorphisms, custom array annotation, and information on complementary cellular, functional, and behavioral traits. The data include male and female samples from 28 common strains, 68 BXD recombinant inbred lines, as well as several mutants and knockouts. Results: We provide a fully integrated resource to map, graph, analyze, and test causes and correlations of differences in gene expression in the eye. Covariance in mRNA expression can be used to infer gene function, extract signatures for different cells or tissues, to define molecular networks, and to map quantitative trait loci that produce expression differences.
    [Show full text]
  • Engineered Type 1 Regulatory T Cells Designed for Clinical Use Kill Primary
    ARTICLE Acute Myeloid Leukemia Engineered type 1 regulatory T cells designed Ferrata Storti Foundation for clinical use kill primary pediatric acute myeloid leukemia cells Brandon Cieniewicz,1* Molly Javier Uyeda,1,2* Ping (Pauline) Chen,1 Ece Canan Sayitoglu,1 Jeffrey Mao-Hwa Liu,1 Grazia Andolfi,3 Katharine Greenthal,1 Alice Bertaina,1,4 Silvia Gregori,3 Rosa Bacchetta,1,4 Norman James Lacayo,1 Alma-Martina Cepika1,4# and Maria Grazia Roncarolo1,2,4# Haematologica 2021 Volume 106(10):2588-2597 1Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 2Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford School of Medicine, Stanford, CA, USA; 3San Raffaele Telethon Institute for Gene Therapy, Milan, Italy and 4Center for Definitive and Curative Medicine, Stanford School of Medicine, Stanford, CA, USA *BC and MJU contributed equally as co-first authors #AMC and MGR contributed equally as co-senior authors ABSTRACT ype 1 regulatory (Tr1) T cells induced by enforced expression of interleukin-10 (LV-10) are being developed as a novel treatment for Tchemotherapy-resistant myeloid leukemias. In vivo, LV-10 cells do not cause graft-versus-host disease while mediating graft-versus-leukemia effect against adult acute myeloid leukemia (AML). Since pediatric AML (pAML) and adult AML are different on a genetic and epigenetic level, we investigate herein whether LV-10 cells also efficiently kill pAML cells. We show that the majority of primary pAML are killed by LV-10 cells, with different levels of sensitivity to killing. Transcriptionally, pAML sensitive to LV-10 killing expressed a myeloid maturation signature.
    [Show full text]
  • Structural Diversity of Neuronal Calcium Sensor Proteins and Insights for Activation of Retinal Guanylyl Cyclase by GCAP1
    REVIEW ARTICLE published: 17 March 2014 doi: 10.3389/fnmol.2014.00019 Structural diversity of neuronal calcium sensor proteins and insights for activation of retinal guanylyl cyclase by GCAP1 Sunghyuk Lim1, Alexander M. Dizhoor 2 and James B. Ames 1* 1 Department of Chemistry, University of California at Davis, Davis, CA, USA 2 Basic Sciences, Pennsylvania College of Optometry, Salus University, Elkins Park, PA, USA Edited by: Neuronal calcium sensor (NCS) proteins, a sub-branch of the calmodulin superfamily, Rameshwar K. Sharma, Salus are expressed in the brain and retina where they transduce calcium signals and are University, USA genetically linked to degenerative diseases. The amino acid sequences of NCS proteins Reviewed by: are highly conserved but their physiological functions are quite different. Retinal recoverin Baojin Ding, University of 2+ Massachusetts Medical School, USA controls Ca -dependent inactivation of light-excited rhodopsin during phototransduction, + Frank Schmitz, Saarland University, guanylyl cyclase activating proteins 1 and 2 (GCAP1 and GCAP2) promote Ca2 -dependent Germany activation of retinal guanylyl cyclases, and neuronal frequenin (NCS-1) modulates synaptic *Correspondence: activity and neuronal secretion. Here we review the molecular structures of myristoylated James B. Ames, Department of forms of NCS-1, recoverin, and GCAP1 that all look very different, suggesting that the Chemistry, University of California at Davis, One Shields Avenue, Davis, CA attached myristoyl group helps to refold these highly homologous proteins into different + 95616, USA three-dimensional folds. Ca2 -binding to both recoverin and NCS-1 cause large protein e-mail: [email protected] conformational changes that ejects the covalently attached myristoyl group into the solvent exterior and promotes membrane targeting (Ca2+-myristoyl switch).
    [Show full text]